The feminization of HPV: How science, politics, economics and gender norms shaped U.S. HPV vaccine implementation
Human papillomavirus (HPV) can cause a number of anogenital cancers (i.e., cervical, penile, anal, vaginal, vulvar) and genital warts. A decade ago, the HPV vaccine was approved, and has been shown to be a public health achievement that can reduce the morbidity and mortality for HPV-associated disea...
Main Authors: | Ellen M. Daley, Cheryl A. Vamos, Erika L. Thompson, Gregory D. Zimet, Zeev Rosberger, Laura Merrell, Nolan S. Kline |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-06-01
|
Series: | Papillomavirus Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405852116300593 |
Similar Items
-
Are dental providers the next line of HPV-related prevention? Providers’ perceived role and needs
by: Nolan Kline, et al.
Published: (2018-06-01) -
Psychosocial correlates of HPV vaccine acceptability in college males: A cross-sectional exploratory study
by: Ovidiu Tatar, et al.
Published: (2017-12-01) -
HPV vaccination in Papua New Guinea to prevent cervical cancer in women: Gender, sexual morality, outsiders and the de-feminization of the HPV vaccine
by: Angela Kelly-Hanku, et al.
Published: (2019-12-01) -
Oral HPV prevalence and HPV vaccination among special needs population in the US
by: Siddardha G. Chandrupatla, et al.
Published: (2019-12-01) -
Vaccinating sons against HPV: results from a U.S. national survey of parents.
by: Jaime L Taylor, et al.
Published: (2014-01-01)